Risk factors for acquiring sporadic Campylobacter infection in France: Results from a national case-control study

Journal of Infectious Diseases

Volumn 197, Issue 10, 2008, Pages 1477-1484

  Gallay, Anne ^a   Bousquet, Vanina ^a   Siret, Virginie ^a   Prouzet Mauléon, Valérie ^b   De Valk, Henriette ^a   Vaillant, Véronique ^a   Simon, Fernando ^a   Le Strat, Yann ^a   Mégraud, Francis ^b   Desenclos, Jean Claude ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b Centre Nat'l Ref Campylobacters   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; GENTAMICIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER; CAMPYLOBACTER JEJUNI; CASE CONTROL STUDY; CONTROLLED STUDY; FOOD CONTAMINATION; FRANCE; GRAM NEGATIVE INFECTION; HUMAN; HYGIENE; INTERVIEW; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TRAVEL;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FEMALE; FOOD HANDLING; FRANCE; HUMANS; HYGIENE; INFANT; MALE; RISK FACTORS;

EID: 43949104067     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/587644     Document Type: Article

References (48)

1. Frost JA. Current epidemiological issues in human campylobacteriosis. Symp Ser Soc Appl Microbiol 2001; 90:85S-95S.
2. Allos BM, Blaser MJ. Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis 1995; 20:1092-9.
3. Saeed AM, Harris NV, DiGiacomo RF. The role of exposure to animals in the etiology of Campylobacter jejuni/coli enteritis. Am J Epidemiol 1993; 137:108-14.
4. Ikram R, Chambers S, Mitchell P, Brieseman MA, Ikam OH. A case control study to determine risk factors for campylobacter infection in Christchurch in the summer of 1992-3. N Z Med J 1994; 107:430-2.
5. Eberhart-Phillips J, Walker N, Garrett N, et al. Campylobacteriosis in New Zealand: results of a case-control study. J Epidemiol Community Health 1997; 51:686-91.
6. Studahl A, Andersson Y. Risk factors for indigenous Campylobacter infection: a Swedish case-control study. Epidemiol Infect 2000; 125:269-75.
7. Neimann J, Engberg J, Mølbak K, Wegener HC. A case-control study of risk factors for sporadic Campylobacter infections in Denmark. Epidemiol Infect 2003; 130:353-66.
8. Schönberg-Norio D, Takkinen J, Hänninen ML, et al. Swimming and Campylobacter infections. Emerg Infect Dis 2004; 10:1474-7.
9. Friedman CR, Hoekstra RM, Samuel M, et al. Risk factors for sporadic Campylobacter infection in the United States: a case-control study in FoodNet sites. Clin Infect Dis 2004; 38(Suppl 3):S285-96.
10. Michaud S, Ménard S, Arbeit RD. Campylobacteriosis, Eastern Townships, Quebec. Emerg Infect Dis 2004; 10:1844-7.
11. Kapperud G, Skjerve E, Bean NH, Ostroff SM, Lassen J. Risk factors for sporadic Campylobacter infections: results of a case-control study in southeastern Norway. J Clin Microbiol 1992; 30:3117-21.
12. Rodrigues LC, Cowden JM, Wheeler JG, et al. The study of infectious intestinal disease in England: risk factors for cases of infectious intestinal disease with Campylobacter jejuni infection. Epidemiol Infect 2001; 127:185-93.
13. Tenkate TD, Stafford RJ. Risk factors for campylobacter infection in infants and young children: a matched case-control study. Epidemiol Infect 2001; 127:399-404.
14. Adak GK, Cowden JM, Nicholas S, Evans HS. The Public Health Laboratory Service national case-control study of primary indigenous sporadic cases of campylobacter infection. Epidemiol Infect 1995; 115:15-22.
15. Scott DA, Tribble DR. Protection against Campylobacter infection and vaccine development. In: Nachamkin I, Blaser MJ, eds. Campylobacter. 2nd ed. ASM Press, 2000:303-48.
16. Frost JA, Gillespie IA, O'Brien SJ. Public health implications of Campylobacter outbreaks in England and Wales, 1995-9: epidemiological and microbiological investigations. Epidemiol Infect 2002; 128:111-8.
17. Kirk M, Waddell R, Dalton C, Creaser A, Rose N. A prolonged outbreak of Campylobacter infection at a training facility. Commun Dis Intell 1997; 21:57-61.
18. Mazick A, Ethelberg S, Nielsen EM, Mølbak K, Lisby M. An outbreak of Campylobacter jejuni associated with consumption of chicken, Copenhagen, 2005. Euro Surveill 2006; 11:137-9.
19. Gallay A, de Valk H, Cournot M, Ladeuil B, et al. A large multi-pathogen waterborne community outbreak linked to faecal contamination of a groundwater system, France, 2000. Clin Microbiol Infect 2006; 12:561-70.
20. Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 2001; 7:24-34.
21. Luber P, Wagner J, Hahn H, Bartelt E. Antimicrobial resistance in Campylobacter jejuni and Campylobacter coli strains isolated in 1991 and 2001-2002 from poultry and humans in Berlin, Germany. Antimicrob Agents Chemother 2003; 47:3825-30.
22. Gupta A, Nelson JM, Barrett TJ, et al. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg Infect Dis 2004; 10:1102-9.
23. Vaillant V, de Valk H, Baron E, et al. Foodborne infections in France. Foodborne Pathog Dis 2005; 2:221-32.
24. Gallay A, Simon F, Mégraud F. Surveillance of human Campylobacter infections in France - part 2 - implementation of national surveillance. Euro Surveill 2003; 8:218.
25. Société Française de Microbiologie (SFMG). Recommendations du Comite de l'Antibiogramme de la Société Française de Microbiologie. Available at: http://www.sfm.asso.fr/nouv/ general.php?pa=2. Accessed January 2005.
26. Rubin DB. Multiple imputation after 18+ years. Am Stat Assoc 1996; 91:473-89.
27. Royston P. Multiple imputation of missing values: update. Stata Journal 2005; 5:188-201.
28. Fullerton KE, Ingram LA, Jones TF, et al. Sporadic campylobacter infection in infants a population-based surveillance case-control study. Pediatr Infect Dis J 2007; 26:19-24.
29. Office National Interprofessionnel des Viandes. Consommation des produits carnés en 2003. Available at: http://www.office-elevage.fr/publications/ cahier/conso03/conso03.htm. Accessed 14 March 2008.
30. Hérau V. Risque sanitaires microbiologiques lié aux effluents d'abattoirs: comparaison d'une synthèse bibliographique avec une étude de terrain. Toulouse, France: Thèse-Université Paul Sabatier, 2003.
31. Agence Française de Sécurité Sanitaire des Aliments. Appréciation des risques alimentaires liés aux campylobacters: application au couple poulet/Campylobacter jejuni. Available at: http://www.afssa.fr/Documents/MIC-Ra-campylobacter.pdf. Accessed 14 March 2008.
32. Kapperud G, Espeland G, Wahl E, et al. Factors associated with increased and decreased risk of Campylobacter infection: a prospective casecontrol study in Norway. Am J Epidemiol 2003; 158:234-42.
33. Cameron S, Ried K, Worsley A, Topping D. Consumption of foods by young children with diagnosed Campylobacter infection - a pilot casecontrol study. Public Health Nutr 2004; 7:85-9.
34. Potter RC, Kaneene JB, Hall WN. Risk factors for sporadic Campylobacter jejuni infections in rural Michigan: a prospective case-control study. Am J Public Health 2003; 93:2118-23.
35. Carrique-Mas J, Andersson Y, Hjertqvist M, Svensson A, Torner A, Giesecke J. Risk factors for domestic sporadic campylobacteriosis among young children in Sweden. Scand J Infect Dis 2005; 37:101-10.
36. Agence Française de Sécurité Sanitaire des Aliments. Farm 2003-2004 French antibiotic resistance monitoring in bacteria of animal origin. Available at: http://www.afssa.fr/Documents/SANT-Ra-FARM.pdf. Accessed 14 March 2008.
37. Moore JE, Barton MD, Blair IS, et al. The epidemiology of antibiotic resistance in Campylobacter. Microbes Infect 2006; 8:1955-66.
38. Swift L, Hunter PR. What do negative associations between potential risk factors and illness in analytical epidemiological studies of infectious disease really mean? Eur J Epidemiol 2004; 19:219-23.
39. Cowden J. Campylobacter: epidemiological paradoxes. BMJ 1992; 305:132-3.
40. Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ. Experimental Campylobacter jejuni infection in humans. J Infect Dis 1988; 157:472-9.
41. Delarocque-Astagneau E, Desenclos JC, Bouvet P, Grimont PA. Risk factors for the occurrence of sporadic Salmonella enterica serotype enteritidis infections in children in France: a national case-control study. Epidemiol Infect 1998; 121:561-7.
42. Ethelberg S, Olsen KE, Gerner-Smidt P, Mølbak K. Household outbreaks among culture-confirmed cases of bacterial gastrointestinal disease. Am J Epidemiol 2004; 159:406-12.
43. Hakanen A, Jousimies-Somer H, Siitonen A, Huovinen P, Kotilainen P. Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. Emerg Infect Dis 2003; 9:267-70.
44. Ekdahl K, Giesecke J. Travellers returning to Sweden as sentinels for comparative disease incidence in other European countries, campylobacter and giardia infection as examples. Euro Surveill 2004; 9:6-9.
45. Smith KE, Besser JM, Hedberg CW, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med 1999; 340:1525-32.
46. Effler P, Ieong MC, Kimura A, et al. Sporadic Campylobacter jejuni infections in Hawaii: associations with prior antibiotic use and commercially prepared chicken. J Infect Dis 2001; 183:1152-5.
47. Vach W, Blettner M. Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. Am J Epidemiol 1991; 134:895-907.
48. Chavance M, Manfredi R. Modeling incomplete observations [in French]. Rev Epidemiol Sante Publique 2000; 48:389-400.